Professional Documents
Culture Documents
Corporate Reporting - ND2020 - Suggested - Answers - Review by SB
Corporate Reporting - ND2020 - Suggested - Answers - Review by SB
Suggested Answers
W1 Cost of Sale s
Sale or re turn
Sales Revenue will decrease by Tk. 7,800 and Current Assets will decrease Tk. 7,800.
Mark up = 30%
130% = 7,800
100/130 * 7,800 = 6,000
Current Assets will increase Tk. 6,000 and Cost of Sales will reduce Tk. 6,000
W2 De preciation/Amortisation
Prope rty
Land 3,000
Building 27,000
27,000/18 years = 1,500 depreciation
W4 Re tained Earnings
W5)
Under IFRS 15, each component should be measured separately. As only three months of the
maintenance service has been provided, we should only recognize 3/24 of the maintenance fee as
revenue in the year ended 30 June 2020. The remainder should be treated as deferred income and
recognized as the service is being provided.
The sale of goods, however, should be recognized immediately. As the total of the fair values
exceeds the overall price of the contract, a discount has been provided.
As we do not know what has been discounted, it would seem reasonable to apply the same discount
percentage to each separate component.
Deferred income should be measured at TK.3500 (21/24 x TK.500 x 80%). Revenue (retained earnings
should therefore be reduced by TK3500.
Page 2 of 13
Dr Retained earnings 350
Cr Deferred Income (CL) 350
Alte rnative pre se ntation for IFRS 15 for Re ve nue re cognition:
Product sale (Tk.5 million / Tk. 5 million + Tk.0.5 million x Tk.4.4 million 4000
W-6)
The initial carrying value of the bond will be as follows:
Amount in '000 Taka
Purchase price (90% of Tk.5000) 4,500
Add: Purchase costs 50
Total asset cost recognized 4,550
Finance income will be recognized @ 7.3% of the opening carrying value 332
Financial assets measured at amortized costs
Finance
Interest
Asset at the Asset at the
Year Income
Received
beginning end
(7.3%) (6%)
Taka in Taka in
Taka in Th Taka in Th
thousand Th
2019-2020 4,550 332 (300) 4,582
To : Managing Partner
From : Golam Morshed
Subject : Regarding Audit Procedure and Finalization of Consolidated Financial Statements of Surma Industries Limited
(SIL)
Dear Sir,
Please find your required information below:
(a) Financial reporting treatment of the matters raised in the Farzana’s Working Paper
1. 100% owned Subsidiary
As Turag has been recognised as a subsidiary since 2010, the acquisition of a further 20% does not result in any change in
control. As a result, no gain or loss will be recorded. The proposed fair valuation exercise is therefore not required.
The accounting entries required in the consolidated financial statements will be as follows:
DR: Non-controlling interest BDT 266 M
DR: Shareholders equity (balancing figure) BDT 114 M
Page 3 of 13
CR: Cash (or elimination of investment in holding company) BDT380 M
The bond issue should be accounted for as a compound financial instrument with a liability element and an equity element.
The liability element of the gross proceeds is calculated as the net present value of the maximum cash flows at the rate of
interest for a similar bond without conversions rights, 8%:
Hence of the BDT 950 million gross proceeds, BDT 876.72 million should be shown as a liability payable (on issue). The
remaining balance of BDT 73.28 should be shown as equity. The effect on profit before taxation will be charge of 3 months
interest on the bond. This will be BDT 876.72 M @ 8% x 3/12 = BDT 17.53 million.
IFRS 10 paragraph 12 states that 'An investor with the current ability to direct the relevant activities has power, even if its
rights have yet to be exercised'. IFRS 10 paragraph B47 also requires an investor to consider potential voting rights in
considering whether it has control and (paragraph B22) whether they are substantive, i.e. whether the holder has the
practical ability to exercise the right.
Although SIL does not have the majority of the voting rights in Rupsa and there are other powerful investors, two factors in
accordance with IFRS10 suggest that SIL may still have control and should therefore account for Rupsa as a subsidiary
rather than as an associate.
(i) It has the power to affect its returns from Rupsa through its control of Board decisions over research and
development, arguably the most important decisions in a research driven entity such as Rupsa.
(ii) It has the right to acquire further shares through its call option. The exercise of this option will give it a
majority holding of 65%. In this case the rights to acquire further shares appear to be substantive as SIL’s
additional 20% holding will cost it BDT 142.5 million compared to the BDT 285 million it paid for its initial
45% shareholding. While this is a higher amount per share it is not substantially higher and can reasonably be
expected to be a competitive price for a stake which takes it to a majority holding in the company.
Accounting for Rupsa as a subsidiary means that 100% of its results, assets and liabilities will be consolidated within the
group financial statement and the 55% share not owned by the group will be accounted for as a non-controlling interest.
The acquisition will have a significant impact on the group statement of cash flows with the investment shown within
investing activities.
Using the share of net assets method to determine goodwill on acquisition and the net asset information provided will give a
goodwill figure of BDT 285 million - (45% of BDT 19 million) = BDT 276.45 million which will be included as an
intangible asset in the group financial statements and will need to be subjected to a review for impairment.
However further consideration needs to be given to whether some / most of this value should be attributed to intangible
assets which are not shown at present on Rupsa’s statement of financial position. In particular, there may well be value in
the research and development project for the new material which appears to have reached the commercial exploitation stage.
Thus, this project should be valued as a separable intangible on acquisition (and subsequently within the consolidated
Page 4 of 13
financial statements) if it could be sold separately from Rupsa and has a stand-alone value. Treatment as a separable
intangible will also affect group accounts in future years as intangibles other than goodwill are amortised through the
statement of consolidated profit or loss.
As Rupsa is accounted for as a subsidiary, its loss for the 3 months ending 30 June 2020 will be included in group profit
before taxation (although 55% of it will then be attributed to the non-controlling shareholders) – therefore adjustment
required of BDT 28.5 M x 3/12 = BDT 7.125 million.
Given Rupsa’s loss for the year, an impairment review should also be considered.
As a significant interest in Tista is expected to be retained, Tista will be an associate following the part disposal. The loss of
control triggers the need to re-measure goodwill and the retained interest will therefore be valued not at net asset value but at
fair value.
Therefore the SIL’s team is correct in its recommendation of the accounting treatment in this instance however the
calculation of the gain on disposal is incorrect. There is in fact a small loss, calculated as shown below:
BDT million
Proceeds received 570
Fair value of 25% interest retained 95
665
Less:
Net assets of Tista 532
Goodwill 142.5
(674.5)
Loss on disposal in group
accounts (9.5)
This loss includes the downward revaluation to fair value of the remaining non-controlling interest, thus explaining why it is
different to the calculation performed by SIL’s finance team.
The full results of Tista will be included in the consolidated statement of profit or loss account up to 30 April 2020. From
that date onwards just the group’s share of Tista’s loss after tax will be included and this will also be deducted from the
carrying value of the investment in Tista in the consolidated statement of financial position.
Tista will be included as an associate rather than a subsidiary for the last two months of the year. This will mean that rather
than a loss of BDT 285m x 2/12 = BDT 47.5m, only a loss of 25% of that amount (BDT 11.875) will be included in profit
before taxation. Therefore, an adjustment of BDT 11.875.
As Tista has been making losses it is possible that it will not succeed under its new owners and the remaining investment in
the company will need to be reviewed for impairment.
An impairment adjustment will be required if the carrying amount is lower than the higher of the value in use and the fair
value less selling costs. The value in use is BDT 874 million which is below the carrying amount and therefore an
impairment charge should be recorded. The following calculation assumes that it is correct to use the value in use. If the fair
value less costs to sell the remaining business were higher than that figure should be substituted in the calculations above
giving a lower impairment charge.
The impairment in the overall value of Gomati needs to be allocated between SIL and the non-controlling interest. As the
non-controlling interest is determined using the proportion of net assets method, there needs to be a notional grossing up of
goodwill in order to compare the carrying and recoverable amounts.
The parent company’s goodwill of BDT 380 million needs to be notionally adjusted to include the NCI notional goodwill of
BDT 95 million (20%/80% x BDT 380 million) giving a total goodwill figure of BDT 475 million.
Hence the impairment can be calculated as:
BDT m
Net separable assets 760
Goodwill 475
1,235
Value in use (874)
Page 5 of 13
Impairment 361
Of the total impairment, 80% is allocated to SIL giving a goodwill impairment of BDT 288.8 million to be recorded in the
financial statements which is allocated first to goodwill.
Whether there are other costs which should be provided for? There are likely to be redundancy costs and other costs of
closure / disposal which should be provided for at the point at which a detailed plan and announcement have been made
(IAS 37). It is not clear from the information given whether this is the case or will be by year end. However, both the
amount of the required provision and the timing of its recognition need further consideration.
(b) Effect on consolidated profit before tax for the year ending 30 June 2020.
BDT M
Projected profit before adjustments 665
Turag – no effect on profit before taxation but will affect the amount of profit attributable to the non-controlling 0
interest as this will be 20% to 31 March and nil thereafter.
Bond issue – effect on profit before taxation will be charge of 3 months interest on the bond. At 8% on BDT -5.66
876.72 M BDT ((876.72 M @ 8% x 3/12) – (950M @5% X 3/12))
Rupsa – as Rupsa is accounted for as a subsidiary, its loss for the 3 months ending -7.125
31 March will be included in group profit before taxation (although 55% of it will then be attributed to the non-
controlling shareholders) BDT 28.5 M x 3/12 = BDT 7.125 M.
Tista – loss on disposal netted off by previous recognized gain (-9.5 M – 28.5 M) -38
In addition, Tista will be included as an associate rather than a subsidiary for the last two months of the year.
This will mean that rather than a loss of BDT 3m x 2/12 = BDT 500,000, only a loss of 25% of that amount
(BDT 125k) will be included in profit before taxation. -11.875
Gomati - Impairment charge -288.8
Adjusted projected profit before taxation 313.54
The group auditor’s ability to obtain sufficient evidence will be affected by significant changes in the group such as those
for SIL. Identification of significant components may change as entities are added to the group or sold off or as the relative
materiality of their operations change. The group auditor should be involved in the assessment of risk for all significant
components which will require a full audit using component materiality; and audit of specified balances related to
significant risks.
If work done at significant components does not provide sufficient audit evidence , then some non-significant components
will be selected and additional procedures performed at those rather than the analytical reviews performed in the past.
Changes in the group may mean that such an approach becomes necessary.
In this case, work at the components is performed by other teams from the firm but the group audit partner will still need to
be involved in planning and directing the work of those teams to ensure that sufficient assurance is given at group level.
Turag
- As Turag has been a subsidiary for some time, few additional audit procedures are likely to be required.
- However, the sale by the Chief Executive of his shares does increase his incentive to overstate the results of the
company in the period to 01 April 2020. There is therefore an enhanced risk of management override of controls and
fraud. The subsidiary audit team should be made aware of this and asked to report to the group team on the results of
focussed audit procedures on journal entries and judgemental provisions.
- The results as at 01 April 2020 will determine the entry made to reserves and therefore some additional work may be
required to look at whether an accurate cut off in revenue and costs was achieved at that date. Any unusual trends in
the last 3 months compared to the earlier part of the year should also be thoroughly investigated.
- The sale and purchase agreement for the shares should be reviewed to identify key terms and ascertain any
performance conditions or additional liabilities.
- The entries made to record the new investment and the elimination of the non-controlling interest balance should be
Page 6 of 13
reviewed to ensure that they are accurate.
- The terms of the convertible loan agreement should be reviewed and agreed to the loan agreement document and
ensure that the financial reporting treatment agrees to the terms.
- In particular, the sources for the comparable interest rate should be checked as it is this which drives the split of the
compound instrument for accounting purposes. A higher or lower rate could make a significant difference.
- The bond is above planning materiality and is a complex transaction and requires scrutiny given the lack of
experience of the client’s staff.
- Review purchase agreement and loan agreement to identify key terms and form an independent assessment as to
whether SIL has control over Rupsa and whether there are other key terms which should be considered in forming
that assessment or determining the amounts to be included in the financial statements.
- Assess the date at which control passed and ensure that Rupsa’s results and cash flows have been consolidated from
that date. Given the immateriality of Rupsa’s results to the group, detailed audit work at the subsidiary level is
unlikely to be required, although consideration should be given to the total level of costs incurred and whether any
material amounts should have been capitalised as R&D – this is unlikely in current year as total loss only expected to
be BDT 28.5 million and this is likely to equate to the costs as no significant revenue expected in start-up phase.
- Ensure that the investment balance held in the holding company has been eliminated on consolidation and that the
goodwill shown has been correctly calculated and disclosed. Check that the investment is correctly included in the
group cash flow statement as an investing cash flow.
- Obtain details of the fair values attributed to assets and liabilities at the date of acquisition. For each significant item
(tangible assets and net current assets are unlikely to be significant based on information provided), consider the
basis for the fair value and assess the reliability of any valuations provided by external experts. This is most likely to
be relevant for separable intangibles such as R&D.
- Ensure that we have sufficient understanding of Rupsa’s operations and commitments to be able to assess whether
the assets and liabilities at the acquisition date are reasonable and complete as it is possible that liabilities may have
been missed or that the identification of separable intangible assets is incomplete. Consider the monitoring controls
which SIL exercises over Rupsa and discuss plans for the company with the SIL nominated Rupsa directors.
- Review Rupsa’s business plans and consider whether there is any indication that the goodwill and / or intangibles are
impaired. There will inevitably be significant judgement involved in the valuation of a research company and the
assessment performed at the time of the acquisition and basis for the offer of BDT 285 million should be relevant in
making this assessment. While significant change would not normally be expected in just a few months it is possible
that a research breakthrough or developments made by a competitor could have a significant effect on the prospects
of New Material project and Rupsa and we need to make enquiries as to whether this is the case. A change in key
personnel, particularly those developing the project, would also be significant.
Tista
- Review sale agreement and ensure in particular that all costs have been recognised and that consideration has been
given to any liabilities or contingent liabilities arising from guarantees or warranties given to the purchaser.
- Consider the terms of the agreement with the new majority shareholder and assess whether SIL’s finance team is
correct in saying that SIL retains significant interest and should therefore account for Tista as an associate.
- Review the accuracy of the accounting entries made to reflect the disposal.
- Consider the extent of procedures required at Tista to provide assurance on the results consolidated for 10 months
(which may still mean it is a significant component) and also whether additional audit procedures are required at the
disposal date at Tista to verify the accuracy of the net asset balance used in the disposal calculation and the split of
results between the period when Tista was a wholly owned subsidiary and that when it is an associate. In considering
the level of work required we should take into account any due diligence procedures undertaken by the acquirer
(although we are unlikely to be given access to these) and whether a closing date audit is planned on which we may
be able to rely.
- Consider whether the inclusion of Tista as an associate changes our overall assessment of the work required on the
associate balances – Tista was considered significant when a subsidiary. It may be that in the future it is audited by a
Page 7 of 13
different component auditor and that will give rise to the need to assess that auditor and determine the level of
assurance gained from their work.
Gomoti
- The key judgement in the impairment calculation is the amount of the value in use. Obtain detailed projections
supporting the value of BDT 874 million and subject both cash flows and discount rate to scrutiny comparing cash
flows to past results, sales order levels etc. and reviewing / performing sensitivity analysis for the key assumptions
made.
- There may also be going concern indications and a going concern review should be considered.
- The amounts to be included in the consolidated statement of financial position for Gomoti will be lower than in the
prior year (as will its contribution to profit and revenue as business is declining). Need to consider therefore whether
Gomoti is still a significant subsidiary entity (although it seems likely that this is the case given the size of its
remaining value in use).
- Also need to consider whether, given Gomoti’s diminishing contribution and also the disposal of Gomoti, work will
be required at some of the subsidiaries previously considered insignificant in order to obtain sufficient coverage of
key balances across the group.
Total Expected credit loss allowance to be provided is BDT 144,635. As ECL allowance of BDT 95,000 already
provided for in prior year, incremental amount of (144,635 – 95,000) = BDT 49,635 need to be recognized in the
current year financial statements.
Journal entry to be passed:
Expenses for expected credit loss Dr 49,635
Allowance for Expected credit loss Cr 49,635
Based on the calculation, on 30 June 2019, expenses should have been recognized at BDT 30075,000 and the same
amount should be booked for the year ended on 30 June 2020 and 30 June 2021 expenses should be recognized at
475,000. Vesting period for share option will end on next year and after charging expenses related to subsequent year,
shares will be issued to the head of departments.
The aforementioned treatment will require restatement of financial statement for the year ended on 30 June 2019.
For recording remuneration expenses related to current year
Retained EarningsRemuneration expenses Dr 300,000475,000
EquityShare to be issued Cr 475,000300,000
Requirement (b):
Evidence to be collected:
ETL’s policies and governance framework that include how the it determined to select the drivers of credit
losses it forecasts and links to ECL.
Page 9 of 13
Documentations of process on ECL model.
Summary of controls developed for ECL models.
Results from testing of control for ECL Model.
Results from testing for accuracy and consistency for information used in calculating probability of default and
loan given default.
Historical data used in ECL calculation.
Basis used for developing probability of default and loss given default.
Results from inquiry made to the internal auditors.
Third party confirmations for the outstanding balances.
ECL Calculation prepared by the management.
View documentation to verify option terms such as exercise price and term to vesting date.
Ensure relevant heads of departments are still employed.
Investigate whether there was any indication that they might leave in the past as this could affect estimation basis
of the prior period adjustment.
Determine the basis on which the fair value of the options has been calculated- should be based on appropriate
valuation based on marker prices wherever possible. If an option pricing model has been used, determine which
method has been adopted an whether it is appropriate and reflects the nature of the options.
Confirm that the fair value is calculated as at the rant date and that this is when offer and acceptance has taken
place.
Recalculate the fair value using the same inputs and consider obtaining expert advice if applicable.
Check volatility to published statistics.
Agree share price at issue to market price on that date.
Agree risk free rate appropriate at the time of granting options.
Assess whether there are any terms of the share options which five the head of departments a choice of exercise
through cash receipt as opposed to exercising the share options.
Recalculate the expenses spread over the vesting period.
Obtain written representations from management confirming their view that any assumptions they have used in
measuring fair value are reasonable and that there are no further share-based payment schemes in existence that
have not been disclosed.
Check disclosure is in accordance with IFRS 2.
Evidence to be collected:
Requirement (b):
The CFO should be persuaded that professional ethics are an inherent part of the accounting profession. Professional
ethics are a set of moral standards applicable to all professionals. Each professional body has its own ethical code
which requires its members to adhere to a set of fundamental principles in the course of their professional duty, such as
confidentiality, objectivity, professional behaviour, integrity and professional competence and due care.
Often there may be ethical principles which conflict with the profit motive and it may be difficult to decide on a course
of action. An accountant has an ethical obligation to encourage the board of directors to operate within certain
boundaries when determining the profit figure. Users are becoming reactive to unethical behaviour by directors. This is
leading to greater investment in ethical companies with the result that unethical practices can have a greater impact on
the value of an entity than the reporting of a smaller profit figure. Ethical issues are becoming more and more complex
and it critical to have an underlying structure of ethical reasoning, and not purely be driven by the profit motive.
(a) A list of potential COVID-19 impacts on audit with reference to the related international standards on auditing are given
below:
i) Identifying new risks from COVID-19 related impact and re-assessments of the initial Risk of Material
Misstatement (RMM) and Materiality in line with ‘ISA 315 (Revised) Identifying and Assessing the Risks of
Material Misstatement Trough Understanding the Entity and its Environment’ and ‘ISA 320 Materiality in
planning and Performing an Audit’.
ii) Evaluating applicability of going concern assumption used by management for the preparation of the financial
statements in line with ‘ISA 570 (Revised) Going Concern’.
iii) Considering all subsequent events from the date of year-end to the date signing audit report and assessing
whether these are adjusting or non-adjusting events requiring recognition and disclosure in the financial
statements respectively and auditors obligation in accordance with ‘ISA 560 Subsequent Events’.
iv) Obtaining specific representations from management especially on any estimates and judgments applied related
to COVID-19 related impact in line with ‘ISA 580 Written Representations’.
v) Formulation of Auditor’s Opinion in accordance with ‘ISA 700 (Revised) Forming an Opinion and Reporting on
Financial Statements’, ‘ISA 705 (Revised) Modifications to the Opinion in the Independent Auditor’s Report’,
‘ISA 706 (Revised), Emphasis of Matter Paragraphs and Other Matter Paragraphs in the Independent Auditor’s
Report’.
Page 11 of 13
vi) Due to COVID-19 related impact if any changes is required in Key Audit Matters (KAM) previously
communicated to TCWG, updated KAM should be discussed with Management and TCWG in accordance with
‘ISA 701 Communicating Key Audit Matters in the Independent Auditor’s Report’.
vii) Risk of material misstatements in financial statements due to fraud including fraud risk factors identified
previously may require re-assessment due to pervasive changes in economic environment from COVID-19
related impact and hence the auditor should consider this matter in audit in accordance with ‘ISA 240 The
Auditor’s Responsibilities Relating to Fraud in an Audit of Financial Statements’.
viii) All listed entities in Bangladesh are required to publish annual reports and most likely there would be comments
about COVID-19 and its impact on those entities in their annual reports. The auditor now has an added
responsibility to read and comment on other information published along with the financial statements such as
contents in annual report. Accordingly, the auditor should read such disclosure in the annual report and follow
the steps prescribed in ‘ISA 720 (Revised) The Auditor’s Responsibilities Relating to Other Information’.
Page 12 of 13
Our areas of audit focus included user access We tested the Company’s periodic review of access
management, developer access to the production rights. We inspected requests of changes to systems for
environment and changes to the IT environment. There appropriate approval and authorization. We considered
are key to ensuring that IT dependent and application the control environment relating to various interfaces,
based controls are operating effectively. configuration and other application layer controls
identified as key to our audit.
---The End---
Page 13 of 13